CALYXHA_Logo_White_PNG_300_edited.jpg

A new perspective on inflammation

ABOUT

Calyxha is a private biotech company developing novel small molecule anti-inflammatory drugs. Lead by an experienced team of biotech entrepreneurs and scientists, Calyxha targets multiple inflammatory diseases and is currently in preclinical development.

Calyxha's lead product, CAL-4 is being developed as a safe alternative to corticosteroids for asthma and is due to enter the clinic by 2023.

 © Calyxha Biotechnologies GmbH 2022   |    All Rights Reserved    |     Impressum    |     Privacy policy

  • LinkedIn